We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+11.26%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.36B
AUM Growth
+$63.4M
Cap. Flow
-$63.7M
Cap. Flow %
-4.68%
Top 10 Hldgs %
43.84%
Holding
197
New
3
Increased
50
Reduced
102
Closed
12

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$17.1M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.08M
3
BNY
Bank of New York Mellon
BNY
+$1.4M
4
NEE icon
NextEra Energy
NEE
+$1.4M
5
MET icon
MetLife
MET
+$1.35M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$9.8M
2
PG icon
Procter & Gamble
PG
+$7.29M
3
WMT icon
Walmart Inc
WMT
+$5.81M
4
MMM icon
3M
MMM
+$4.54M
5
GE icon
GE Aerospace
GE
+$3.95M

Sector Composition

Rank Sector Weight
1 Consumer Staples 31.94%
2 Technology 13.38%
3 Financials 12.52%
4 Healthcare 10.12%
5 Communication Services 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAP icon
126
Advance Auto Parts
AAP
$3.37B
$1.14M 0.08%
11,400
-7,000
-38% -$644K
MDLZ icon
127
Mondelez International
MDLZ
$77.7B
$1.02M 0.08%
23,860
-3,600
-13% -$151K
TIF
128
DELISTED
Tiffany & Co.
TIF
$936K 0.07%
9,000
-2,600
-22% -$248K
APD icon
129
Air Products & Chemicals
APD
$66.3B
$935K 0.07%
5,700
– –
VRX
130
DELISTED
VALEANT PHARMACEUTICALS INTL
VRX
$935K 0.07%
+45,000
New +$935K
GSK icon
131
GSK
GSK
$103B
$933K 0.07%
21,040
+8,960
+74% +$414K
AET
132
DELISTED
Aetna Inc
AET
$899K 0.07%
4,985
-170
-3% -$29.2K
BP icon
133
BP
BP
$113B
$875K 0.06%
22,734
-1,894
-8% -$68.6K
NSC icon
134
Norfolk Southern
NSC
$78.8B
$869K 0.06%
6,000
-800
-12% -$107K
GILD icon
135
Gilead Sciences
GILD
$161B
$820K 0.06%
11,450
+200
+2% +$15.2K
WFC icon
136
Wells Fargo
WFC
$261B
$799K 0.06%
13,168
-61,201
-82% -$3.46M
D icon
137
Dominion Energy
D
$62.5B
$778K 0.06%
9,598
– –
MCD icon
138
McDonald's
MCD
$188B
$775K 0.06%
4,500
+100
+2% +$16.8K
IRM icon
139
Iron Mountain
IRM
$38.2B
$772K 0.06%
20,472
– –
BA icon
140
Boeing
BA
$165B
$749K 0.06%
2,540
-500
-16% -$135K
KHC icon
141
Kraft Heinz
KHC
$30.4B
$749K 0.06%
9,634
– –
RDS.A
142
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$740K 0.05%
11,100
+7,600
+217% +$479K
KLAC icon
143
KLA
KLAC
$275B
$725K 0.05%
69,000
+49,000
+245% +$517K
PPL
144
PPL Corp
PPL
$27.3B
$707K 0.05%
22,850
-1,600
-7% -$57.5K
PLD icon
145
Prologis
PLD
$138B
$697K 0.05%
10,800
+7,600
+238% +$496K
ABBV icon
146
AbbVie
ABBV
$458B
$674K 0.05%
6,970
-14,700
-68% -$1.39M
FSLR icon
147
First Solar
FSLR
$21.8B
$628K 0.05%
9,300
-2,800
-23% -$164K
UVSP icon
148
Univest Financial
UVSP
$1.23B
$617K 0.05%
+22,000
New +$651K
ETN icon
149
Eaton
ETN
$157B
$589K 0.04%
7,456
-200
-3% -$15.5K
BABA icon
150
Alibaba
BABA
$269B
$552K 0.04%
3,200
– –
4 5
6
7 8

Similar funds

WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Cullinan Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Cullinan Associates held 197 positions worth $1.36B, up 4.9% from $1.3B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cullinan Associates withdrew a net $63.7M in Q4 2017, closing 12 positions and reducing 102 holdings. Its most notable exit was Valero Energy, an estimated $3.57M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 32% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Cullinan Associates opened a new position in VALEANT PHARMACEUTICALS INTL worth $935K.

  • Cullinan Associates's largest Q4 2017 buy was VALEANT PHARMACEUTICALS INTL: 45,000 shares worth $935K.
  • Cullinan Associates added most to S&P Global in Q4 2017, an estimated $17.1M increase.
  • Cullinan Associates's biggest Q4 2017 reduction was Abbott, cutting an estimated $9.8M.
  • Cullinan Associates fully exited Valero Energy in Q4 2017, selling an estimated $3.57M.
  • Cullinan Associates's ten largest holdings make up 44% of its $1.36B portfolio in Q4 2017.
  • Cullinan Associates opened 3 new positions and closed 12 in Q4 2017.
  • Cullinan Associates's portfolio value rose 4.9% quarter-over-quarter to $1.36B.

Based on Cullinan Associates's 13F filing for Q4 2017, filed 17 Jan 2018.